Patent · US Active

Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of DPP-1

US8481547B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Alfonzo D. Jordan · North Wales, US
Renee Louise Desjarlais · Saint Davids, US
Dennis J. Hlasta · Doylestown, US
Michael H. Parker · Doylestown, US
Carsten Schubert · Phoenixville, US
Kimberly White · North Wales, US

Key dates

Filing date	Dec 16, 2010
Grant date	Jul 9, 2013
Priority date	—
Expiry date	Aug 18, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to substituted benzothiazole and benzoxazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by DPP-1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.